99 related articles for article (PubMed ID: 30393183)
1. Co-delivery of siAlox15 and sunitinib for reversing the new-onset of type 1 diabetes in non-obese diabetic mice.
Peng Y; Wen D; Lin F; Mahato RI
J Control Release; 2018 Dec; 292():1-12. PubMed ID: 30393183
[TBL] [Abstract][Full Text] [Related]
2. Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.
Green-Mitchell SM; Tersey SA; Cole BK; Ma K; Kuhn NS; Cunningham TD; Maybee NA; Chakrabarti SK; McDuffie M; Taylor-Fishwick DA; Mirmira RG; Nadler JL; Morris MA
PLoS One; 2013; 8(2):e56763. PubMed ID: 23437231
[TBL] [Abstract][Full Text] [Related]
3. Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.
Leconet W; Petit P; Peraldi-Roux S; Bresson D
Mol Ther; 2012 Dec; 20(12):2315-25. PubMed ID: 22990670
[TBL] [Abstract][Full Text] [Related]
4. Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.
McDuffie M; Maybee NA; Keller SR; Stevens BK; Garmey JC; Morris MA; Kropf E; Rival C; Ma K; Carter JD; Tersey SA; Nunemaker CS; Nadler JL
Diabetes; 2008 Jan; 57(1):199-208. PubMed ID: 17940120
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes.
Hernandez-Perez M; Chopra G; Fine J; Conteh AM; Anderson RM; Linnemann AK; Benjamin C; Nelson JB; Benninger KS; Nadler JL; Maloney DJ; Tersey SA; Mirmira RG
Diabetes; 2017 Nov; 66(11):2875-2887. PubMed ID: 28842399
[TBL] [Abstract][Full Text] [Related]
6. An apparent role for Alox15 in the pathogenesis of diabetes in the NOD mouse: parsing the supporting genetic data.
Weisberg SP; Leibel RL
Diabetes; 2008 Jan; 57(1):1-2. PubMed ID: 18165353
[No Abstract] [Full Text] [Related]
7. Platelet-type 12-lipoxygenase deletion provokes a compensatory 12/15-lipoxygenase increase that exacerbates oxidative stress in mouse islet β cells.
Conteh AM; Reissaus CA; Hernandez-Perez M; Nakshatri S; Anderson RM; Mirmira RG; Tersey SA; Linnemann AK
J Biol Chem; 2019 Apr; 294(16):6612-6620. PubMed ID: 30792307
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease.
Martínez-Clemente M; Ferré N; Titos E; Horrillo R; González-Périz A; Morán-Salvador E; López-Vicario C; Miquel R; Arroyo V; Funk CD; Clària J
Hepatology; 2010 Dec; 52(6):1980-91. PubMed ID: 20967760
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function.
Villalta SA; Lang J; Kubeck S; Kabre B; Szot GL; Calderon B; Wasserfall C; Atkinson MA; Brekken RA; Pullen N; Arch RH; Bluestone JA
Diabetes; 2013 Aug; 62(8):2870-8. PubMed ID: 23835340
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene glycol)-block-poly(2-methyl-2-benzoxycarbonyl-propylene carbonate) micelles for rapamycin delivery: in vitro characterization and biodistribution.
Lu W; Li F; Mahato RI
J Pharm Sci; 2011 Jun; 100(6):2418-29. PubMed ID: 21264854
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice.
Kumar V; Mundra V; Peng Y; Wang Y; Tan C; Mahato RI
Theranostics; 2018; 8(15):4033-4049. PubMed ID: 30128034
[No Abstract] [Full Text] [Related]
12. Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy.
Ren B; O'Brien BA; Byrne MR; Ch'ng E; Gatt PN; Swan MA; Nassif NT; Wei MQ; Gijsbers R; Debyser Z; Simpson AM
J Gene Med; 2013 Jan; 15(1):28-41. PubMed ID: 23293075
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes.
Rydén AK; Perdue NR; Pagni PP; Gibson CB; Ratliff SS; Kirk RK; Friesen TJ; Haase C; Coppieters K; von Herrath MG; Boursalian TE
J Autoimmun; 2017 Nov; 84():65-74. PubMed ID: 28711285
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
[TBL] [Abstract][Full Text] [Related]
15. TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice.
Cao H; Lu J; Du J; Xia F; Wei S; Liu X; Liu T; Liu Y; Xiang M
Sci Rep; 2015 Oct; 5():14593. PubMed ID: 26459028
[TBL] [Abstract][Full Text] [Related]
16. Downregulated NLRP3 and NLRP1 inflammasomes signaling pathways in the development and progression of type 1 diabetes mellitus.
Liu H; Xu R; Kong Q; Liu J; Yu Z; Zhao C
Biomed Pharmacother; 2017 Oct; 94():619-626. PubMed ID: 28783585
[TBL] [Abstract][Full Text] [Related]
17. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer.
Kumar V; Mondal G; Slavik P; Rachagani S; Batra SK; Mahato RI
Mol Pharm; 2015 Apr; 12(4):1289-98. PubMed ID: 25679326
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
[TBL] [Abstract][Full Text] [Related]
19. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis.
Kumar V; Mondal G; Dutta R; Mahato RI
Biomaterials; 2016 Jan; 76():144-56. PubMed ID: 26524535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
